Skip to main content

LepRb+ cell-specific deletion of Slug mitigates obesity and nonalcoholic fatty liver disease in mice.

Citation
Kim, M. -H., et al. “Leprb+ Cell-Specific Deletion Of Slug Mitigates Obesity And Nonalcoholic Fatty Liver Disease In Mice.”. The Journal Of Clinical Investigation.
Center University of Michigan
Author Min-Hyun Kim, Yuan Li, Qiantao Zheng, Lin Jiang, Martin G Myers, Wen-Shu Wu, Liangyou Rui
Keywords Cell Biology, diabetes, leptin, Metabolism, obesity
Abstract

Leptin exerts its biological actions by activating the long-form leptin receptor (LepRb). LepRb signaling impairment and leptin resistance are believed to cause obesity. The transcription factor Slug - also known as Snai2 - recruits epigenetic modifiers and regulates gene expression by an epigenetic mechanism; however, its epigenetic action has not been explored in leptin resistance. Here, we uncover a proobesity function of neuronal Slug. Hypothalamic Slug was upregulated in obese mice. LepRb+ cell-specific Slug-knockout (SlugΔLepRb) mice were resistant to diet-induced obesity, type 2 diabetes, and liver steatosis and experienced decreased food intake and increased fat thermogenesis. Leptin stimulated hypothalamic Stat3 phosphorylation and weight loss to a markedly higher level in SlugΔLepRb than in Slugfl/fl mice, even before their body weight divergence. Conversely, hypothalamic LepRb+ neuron-specific overexpression of Slug, mediated by AAV-hSyn-DIO-Slug transduction, induced leptin resistance, obesity, and metabolic disorders in mice on a chow diet. At the genomic level, Slug bound to and repressed the LepRb promoter, thereby inhibiting LepRb transcription. Consistently, Slug deficiency decreased methylation of LepRb promoter H3K27, a repressive epigenetic mark, and increased LepRb mRNA levels in the hypothalamus. Collectively, these results unravel what we believe to be a previously unrecognized hypothalamic neuronal Slug/epigenetic reprogramming/leptin resistance axis that promotes energy imbalance, obesity, and metabolic disease.

Year of Publication
2023
Journal
The Journal of clinical investigation
Volume
133
Issue
4
Date Published
03/2023
ISSN Number
1558-8238
DOI
10.1172/JCI156722
Alternate Journal
J Clin Invest
PMID
36512408
PMCID
PMC9927931
Download citation